SEC Form 4 · accession 0001181431-15-004886
Pacira BioSciences, Inc. · PCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Taunia Markvicka
Officer — SVP, Chief Commercial Officer
Period of report
Mar 17, 2015
Accepted (ET)
Mar 19, 2015 · 6:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001396814
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 17, 2015 | M | 8,349 | $5.49 | A | 8,579 | D | |
| Common Stock | holding | — | — | — | 230 | I | By spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $5.49 | Mar 17, 2015 | M | 8,349 | D | — | Dec 28, 2020 | Common Stock | 8,349 | 0 | D |
Explanation of responses
- F1Includes 230 shares of common stock acquired under the issuer's employee stock purchase plan in December 2014.
- F2The stock option vests as follows: 25% of the options vested on December 29, 2011, and the remaining options vested in successive equal monthly installments over the subsequent 36 months.